TriMas Corporation (TRS) AI Stock Analysis
TRS AI stock analysis summary
AI ResearchTriMas Corporation (TRS) designs and manufactures engineered solutions across packaging, aerospace, and specialty industrial markets. As of June 30, 2026, the company held a net cash position of $804.7M and a current ratio of 5.44. For FY2025, TriMas generated $120.1M in net income on $645.7M in revenue.
- Market cap
- $1.39B
- Revenue (TTM)
- $664.4M
- P/E
- 15.8x fwd 19.3x
- 1Y return
- 5.9% S&P 500 16.8%
- Avg. target
- $45.00 16.1% vs last close
Bull case
- TriMas maintains a net cash position of $804.7M alongside a current ratio of 5.44 as of June 30, 2026.
- The stock's EV to EBITDA multiple of 5.4x trades below the US-listed Consumer Cyclical peer median of 11.1x.
- FY2025 free cash flow rebounded to $69.1M, up from $12.8M in FY2024.
Bear case
- Revenue decreased at a 5-year compound annual rate of -3.5% from FY2020 to FY2025.
- Consensus estimates anticipate EPS will fall 21.0% to $1.65 for the fiscal year ending December 31, 2026.
- In the latest quarter ended June 30, 2026, quarterly earnings fell 9.7% year-over-year.
What TriMas does
TriMas Corporation designs, manufactures, and distributes products through three main segments: Packaging, Aerospace, and Specialty Products. The Packaging segment provides dispensing solutions, including foaming and sanitizer pumps, lotion and soap dispensers, perfume sprayers, and trigger sprayers. It also manufactures polymeric and steel caps, closures, and custom injection molded components under brands such as Rieke and Taplast. The Aerospace segment produces fasteners, collars, blind bolts, rivets, ducting, and connectors for commercial and military air management systems. These products serve original equipment manufacturers, distributors, and maintenance providers under brand names including Monogram Aerospace Fasteners and Allfast Fastening Systems.
Growth and profitability
TriMas generated revenue of $857.1M in FY2021 and $893.5M in FY2023, before revenue fell 29.4% to $630.8M in FY2024. In FY2025, revenue increased 2.4% to $645.7M, while net income rose to $120.1M, supported by a 20.3% gross margin and a 2.2% operating margin. Free cash flow improved to $69.1M in FY2025 from $12.8M in FY2024. Over the five years from FY2020 to FY2025, revenue contracted at a compound annual rate of -3.5%. In the latest quarter ended June 30, 2026, quarterly revenue rose 1.6% year-over-year, while quarterly earnings fell 9.7% year-over-year.
Balance sheet and cash flow
As of June 30, 2026, TriMas held $1.24B in cash and short-term investments against total debt of $437.8M, resulting in net cash of $804.7M. Total assets were $2.25B and shareholders' equity was $1.44B, yielding a current ratio of 5.44 and a debt-to-equity ratio of 0.30. In FY2025, capital expenditures totaled $48.4M, while the company directed cash toward $103.3M in share buybacks and $6.6M in dividends paid.
Valuation and performance
At $38.75 on October 16, 2026, TriMas carries a market capitalization of $1.39B and an enterprise value of $601.5M. The stock trades at a trailing P/E of 15.8x and a forward P/E of 19.3x, compared to medians of 18.0x and 14.1x, respectively, for US-listed Consumer Cyclical peers. Its EV to EBITDA ratio is 5.4x, below the peer group median of 11.1x. Over the past year, the stock gained 5.9%, trailing the S&P 500 (SPY) return of 16.8%, and its 5-year return of 26.8% lags the index's 83.0%.
TRS dividend
TriMas pays a forward annual dividend of $0.16 per share, providing a dividend yield of 0.41%. The company maintains a payout ratio of 9.0% and distributes dividends on a quarterly schedule. TriMas has paid consecutive dividends for 6 years, with its most recent ex-dividend date on August 6, 2026.
What analysts expect
Analyst ratings comprise 1 Strong Buy, 1 Buy, 0 Holds, 0 Sells, and 0 Strong Sells. The mean price target is $45.00, which is 16.1% above the last close of $38.75. For the fiscal year ending December 31, 2026, consensus estimates project revenue of $677.7M and EPS of $1.65, reflecting a 21.0% decline. Projections for the following fiscal year anticipate EPS of $2.13 and revenue of $696.6M. TriMas beat EPS estimates in 3 of the last 4 quarters, with its next earnings date on October 29, 2026.
Key risks and what to watch
- Operating margin narrowed to 2.2% in FY2025 from 12.2% in FY2021, reflecting reduced operational profitability.
- Short interest represents 16.1% of the float, indicating significant negative positioning by market participants.
- Annual revenue dropped 29.4% in FY2024, highlighting historical top-line instability.
AI-generated research summary. Written with AI from Quotelinks data as of October 16, 2026 and checked so every figure matches that data. For information only, not investment advice. Disclaimer
About this TRS AI stock analysis
This page is an AI-written research summary of TriMas Corporation (TRS). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.
Related: TRS income statement, TRS balance sheet, TRS key metrics, TRS analyst forecast, TRS chart. See the TRS stock overview for the latest quote and news.
TRS AI stock analysis FAQ
What does TriMas Corporation do?
TriMas Corporation manufactures and distributes engineered products through three segments: Packaging, Aerospace, and Specialty Products. Its offerings include dispensing systems, closures, and aerospace fasteners.
Does TriMas pay a dividend?
Yes, TriMas pays a forward annual dividend of $0.16 per share, representing a 0.41% yield and a 9.0% payout ratio. The dividend is paid quarterly and has been distributed for 6 consecutive years.
What is TriMas's cash and debt position?
As of June 30, 2026, TriMas had $1.24B in cash and short-term investments and $437.8M in total debt, giving it a net cash balance of $804.7M.
What is the Wall Street target price for TRS stock?
The mean analyst price target for TriMas is $45.00, which is 16.1% higher than its closing price of $38.75 on October 16, 2026. The stock currently holds 1 Strong Buy and 1 Buy rating.